ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tris Pharma? Acquires Park Therapeutics americanpharmaceuticalreview
April 30, 2021Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, has acquired Park ... -
HCmed joins Wuxi life science innovation park biospectrumasia
September 08, 2019HCmed specializes on the development of handheld devices for inhaled drug delivery therapy.
Pharma Sources Insight July 2025
